Lim YS - Search Results

1

East Asia expert opinion on treatment initiation for chronic hepatitis B.

Kao JH, Hu TH, Jia J, Kurosaki M, Lim YS, Lin HC, Sinn DH, Tanaka Y, Wai-Sun Wong V, Yuen MF. Kao JH, et al. Among authors: lim ys. Aliment Pharmacol Ther. 2020 Nov;52(10):1540-1550. doi: 10.1111/apt.16097. Epub 2020 Sep 20. Aliment Pharmacol Ther. 2020. PMID: 32951256 Review.

2

A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan.

Bennett H, Waser N, Johnston K, Kao JH, Lim YS, Duan ZP, Lee YJ, Wei L, Chen CJ, Sievert W, Yuan Y, Li H. Bennett H, et al. Among authors: lim ys. Hepatol Int. 2015 Jul;9(3):378-90. doi: 10.1007/s12072-015-9629-x. Epub 2015 Jun 13. Hepatol Int. 2015. PMID: 26071238 Review.

3

All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study.

Kao JH, Lee YJ, Heo J, Ahn SH, Lim YS, Peng CY, Chang TT, Torbeyns A, Hughes E, Bhore R, Noviello S. Kao JH, et al. Among authors: lim ys. Liver Int. 2016 Oct;36(10):1433-41. doi: 10.1111/liv.13128. Epub 2016 Apr 28. Liver Int. 2016. PMID: 27009831 Clinical Trial.

4

Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1.

Kao JH, Yu ML, Peng CY, Heo J, Chu CJ, Chang TT, Lee YJ, Hu TH, Yoon KT, Paik SW, Lim YS, Ahn SH, Isakov V, McPhee F, Hu W, Scott Swenson E, Yin PD, Treitel M. Kao JH, et al. Among authors: lim ys. J Gastroenterol Hepatol. 2017 Dec;32(12):1998-2005. doi: 10.1111/jgh.13796. J Gastroenterol Hepatol. 2017. PMID: 28370350

5

The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis C.

Younossi ZM, Stepanova M, Henry L, Han KH, Ahn SH, Lim YS, Chuang WL, Kao JH, Kinh N, Lai CL, Yuen MF, Chan HL, Lai W. Younossi ZM, et al. Among authors: lim ys. Liver Int. 2018 Jul;38(7):1179-1187. doi: 10.1111/liv.13650. Epub 2018 Jan 25. Liver Int. 2018. PMID: 29197140 Clinical Trial.

6

Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection.

Younossi ZM, Stepanova M, Henry L, Han KH, Ahn SH, Lim YS, Chuang WL, Kao JH, Nguyen KV, Lai CL, Chan HL, Wei L. Younossi ZM, et al. Among authors: lim ys. J Viral Hepat. 2018 Dec;25(12):1429-1437. doi: 10.1111/jvh.12965. Epub 2018 Aug 22. J Viral Hepat. 2018. PMID: 29974665 Clinical Trial.

7

Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia.

Younossi ZM, Henry L, P Ong J, Tanaka A, Eguchi Y, Mizokami M, Lim YS, Dan YY, Yu ML, Stepanova M. Younossi ZM, et al. Among authors: lim ys. Aliment Pharmacol Ther. 2019 Mar;49(6):644-653. doi: 10.1111/apt.15131. Epub 2019 Feb 13. Aliment Pharmacol Ther. 2019. PMID: 30761562

8

High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation.

Choi GH, Kim GA, Choi J, Han S, Lim YS. Choi GH, et al. Among authors: lim ys. Aliment Pharmacol Ther. 2019 Jul;50(2):215-226. doi: 10.1111/apt.15311. Epub 2019 May 28. Aliment Pharmacol Ther. 2019. PMID: 31135074

9

Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.

Liu K, Choi J, Le A, Yip TC, Wong VW, Chan SL, Chan HL, Nguyen MH, Lim YS, Wong GL. Liu K, et al. Among authors: lim ys. Aliment Pharmacol Ther. 2019 Nov;50(9):1037-1048. doi: 10.1111/apt.15499. Epub 2019 Sep 16. Aliment Pharmacol Ther. 2019. PMID: 31524304

10

Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial.

Yuen MF, Agarwal K, Gane EJ, Schwabe C, Ahn SH, Kim DJ, Lim YS, Cheng W, Sievert W, Visvanathan K, Ruby E, Liaw S, Yan R, Huang Q, Colonno R, Lopatin U. Yuen MF, et al. Among authors: lim ys. Lancet Gastroenterol Hepatol. 2020 Feb;5(2):152-166. doi: 10.1016/S2468-1253(19)30346-2. Epub 2019 Nov 9. Lancet Gastroenterol Hepatol. 2020. PMID: 31711752 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

806 results

Search Page